The prevalence of autism spectrum disorders has dramatically increased over the last few decades to the current prevalence of approximately 1%. It is most likely that the increase in autism spectrum disorders is a result of changes in diagnostic criteria that have expanded the range of the disorder spectrum and greater overall disorder awareness in populations.
Scope of the report:
- Gain insight to market potential, including a robust 10-year epidemiology forecast of autism spectrum disorder prevalent cases.
- Understand the key epidemiologic risk factors associated with autism spectrum disorders.
- It is estimated that, during 2011, 6,594,000 prevalent cases of autism spectrum disorders will exist in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK). The largest number of cases will be in the US (2,613,000), with Japan having the next largest number of cases (1,411,000).
- Between 2011 and 2021, the number of autism spectrum disorder prevalent cases in the seven major markets is expected to increase slightly by 3.4%. This weak rising trend is attributable to overall population growth across these markets.
- In 2011, it is estimated that, in the seven major markets, the majority of autism spectrum disorder cases will be autistic disorders (52%). It is estimated that there will be 3.4 million autistic disorder cases and 3.1 million other autism spectrum disorder cases in these markets during 2011.
Reasons to purchase:
- What are the most robust sources for autism spectrum disorder prevalence data?
- How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?
- What are the major influencing factors for autism spectrum disorders that drive the trend in prevalent cases and how are they changing? SHOW LESS READ MORE >
Disease burden overview
Forecast results (2011–21)
Autism spectrum disorder subtype distributions for
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
Definition of autism spectrum disorders
GLOBAL VARIATION AND HISTORICAL TRENDS
Prevalence varies over time across the seven major markets, but very little by geography
Autism spectrum disorder cases often also suffer from mental retardation, epilepsy, and other co-morbidities
Maternal and paternal age
EPIDEMIOLOGIC FORECASTING OF AUTISM SPECTRUM DISORDERS
Sources of epidemiologic data
Prevalence of autism spectrum disorders: Autism and Developmental Disabilities Monitoring Network
Prevalence of autism in a US metropolitan area
No effect of MMR withdrawal on the incidence of autism: a total population study
Description of prevalence forecasting methods
Autism spectrum disorder type
US and five major EU markets
Estimated prevalent cases of autism spectrum disorders and future trends
Segmentation of prevalent cases
Strengths and limitations